Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons
@article{Bckstrm2011ParadoxicalEO,
title={Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons},
author={T. B{\"a}ckstr{\"o}m and D. Haage and M. L{\"o}fgren and I. Johansson and S. K. Bengtsson},
journal={Neuroscience},
year={2011},
volume={191},
pages={46-54}
}Some women have negative mood symptoms, caused by progestagens in hormonal contraceptives or sequential hormone therapy or by progesterone in the luteal phase of the menstrual cycle, which may be attributed to metabolites acting on the GABA-A receptor. The GABA system is the major inhibitory system in the adult CNS and most positive modulators of the GABA-A receptor (benzodiazepines, barbiturates, alcohol, GABA steroids), induce inhibitory (e.g. anesthetic, sedative, anticonvulsant, anxiolytic… CONTINUE READING
Paper Mentions
Observational Clinical Trial
Through a recent cross species translational experiment, researchers have identified a set of
epigenetic marks capable of predicting postpartum depression with greater than 85% accuracy… Expand
| Conditions | Bipolar Disorder, Post Partum Depression |
|---|
99 Citations
Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle
- Medicine
- Neurobiology of Stress
- 2020
- 7
Neurosteroids in the Pathophysiology and Treatment of Mood and Anxiety Disorders
- Medicine
- Current Treatment Options in Psychiatry
- 2018
Prefrontal GABA concentration changes in women—Influence of menstrual cycle phase, hormonal contraceptive use, and correlation with premenstrual symptoms
- Medicine
- Brain Research
- 2015
- 53
- PDF
5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Psychology, Medicine
- Neuropsychopharmacology
- 2016
- 49
- PDF
Multifunctional aspects of allopregnanolone in stress and related disorders
- Psychology, Medicine
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- 2014
- 39
- Highly Influenced
Progesterone, reproduction, and psychiatric illness.
- Medicine
- Best practice & research. Clinical obstetrics & gynaecology
- 2020
Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study
- Psychology, Medicine
- Psychopharmacology
- 2016
- 34
Role of Anticonvulsant and Antiepileptogenic Neurosteroids in the Pathophysiology and Treatment of Epilepsy
- Medicine
- Front. Endocrin.
- 2011
- 52
- PDF
References
SHOWING 1-10 OF 124 REFERENCES
GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
- Biology
- Nature
- 1998
- 502
Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: A pilot study
- Psychology, Medicine
- Psychoneuroendocrinology
- 1997
- 125
GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid.
- Medicine
- Nature
- 1998
- 182
Progesterone selectively increases amygdala reactivity in women
- Psychology, Medicine
- Molecular Psychiatry
- 2008
- 201
- PDF
Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.
- Medicine
- The Journal of clinical endocrinology and metabolism
- 2003
- 67
- PDF
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.
- Biology, Medicine
- Science
- 1986
- 2,104
- PDF
Reversal of neurosteroid effects at α4β2δ GABAA receptors triggers anxiety at puberty
- Psychology, Chemistry
- Nature Neuroscience
- 2007
- 186
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
- Medicine
- The New England journal of medicine
- 1998
- 591
Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone
- Medicine, Psychology
- Psychopharmacology
- 2006
- 62
- PDF